Toggle navigation
Home
Search
Services
Blog
Contact
About
HIV GP120 Glycoconjugate Vaccines
Paoletti, Lawrence C.
Brigham and Women's Hospital, Boston, MA, United States
Search 12 grants from Lawrence Paoletti
Search grants from Brigham and Women's Hospital
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Pregnancy Risk Assessment Monitoring System
University of Massachusetts Center for Clinical and Translational Science
Vascular Biochemistry and Molecular Biology
Evaluation of Control Measures Against Diseases Other Than AIDS-266025459
Treatment of Depression: Cooperative Data Analyses
Recently added grants:
Lc: HIV Prevention Trials Network
SDMC: HIV Prevention Trials Network
SDMC: HIV Vaccine Trials Network
Social Connections and Health among Older Adults Living in Low-income Housing
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI045391-02
Application #
6349912
Study Section
Special Emphasis Panel (ZRG1-VACC (03))
Program Officer
Bradac, James A
Project Start
2000-02-15
Project End
2004-01-31
Budget Start
2001-02-01
Budget End
2004-01-31
Support Year
2
Fiscal Year
2001
Total Cost
$239,547
Indirect Cost
Institution
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 2001
R21 AI
HIV GP120 Glycoconjugate Vaccines
Paoletti, Lawrence C. / Brigham and Women's Hospital
$239,547
NIH 2000
R21 AI
HIV GP120 Glycoconjugate Vaccines
Paoletti, Lawrence C. / Brigham and Women's Hospital
$246,086
Publications
Paoletti, Lawrence C; Kennedy, Ronald C
(2002)
Neutralizing antibody induced in mice by novel glycoconjugates of human immunodeficiency virus type 1 gp120 and env2-3.
J Infect Dis 186:1597-602
Comments
Be the first to comment on Lawrence Paoletti's grant